Mar 20, 2017 articles BenevolentAI Q&A: Techworld meets Dr Jackie Hunter, CEO of BenevolentBio An interview with Jackie Hunter, CEO BenevolentBio, the drug discovery arm of BenevolentAI ARTIFICIAL INTELLIGENCE , DRUG DISCOVERY , BENEVOLENTBIO , JACKIE HUNTER
Dec 6, 2016 articles BenevolentBio’s artificial intelligence could discover a better treatment for ALS DRUG DISCOVERY , ARTIFICIAL INTELLIGENCE , BENEVOLENTBIO , JACKIE HUNTER , DISRUPT LONDON
Nov 8, 2016 articles Janssen licenses drugs to artificial intelligence company JACKIE HUNTER , BENEVOLENTBIO , DRUG DISCOVERY , DEEP LEARNING , ARTIFICIAL INTELLIGENCE , BENEVOLENTAI
Nov 2, 2016 articles Using deep learning to update the drug discovery paradigm: an interview with Professor Jackie Hunter JACKIE HUNTER , BENEVOLENTBIO , DRUG DISCOVERY , DEEP LEARNING , ARTIFICIAL INTELLIGENCE
Oct 6, 2016 articles The last hurrah for scientists? ARTIFICIAL INTELLIGENCE , DEEP LEARNING , BIOSCIENCE , BENEVOLENTBIO
Oct 4, 2016 articles Machine-learning teaches computers to tackle big data BIOSCIENCE , ARTIFICIAL INTELLIGENCE , DEEP LEARNING , BENEVOLENTBIO , JACKIE HUNTER
Sep 2, 2016 articles Opening Up Drug Discovery DRUG DISCOVERY , JACKIE HUNTER , BIOSCIENCE , BENEVOLENTBIO , ARTIFICIAL INTELLIGENCE
Nov 30, 2015 announcements BenevolentAI, the pioneering London-based company using artificial intelligence to advance pharmaceutical development, appoints head of BBSRC as new Chief Executive BENEVOLENTAI , ARTIFICIAL INTELLIGENCE , DEEP LEARNING , JACKIE HUNTER , BIOSCIENCE , BENEVOLENTBIO
